ALGS Competitors & Alternatives
Compare Aligos Therapeutics Inc with similar stocks in the same industry
Biotechnology
ALGS
Main Stock$5.54
Tradestie Score
47
Market Cap
$71.53M
Revenue Growth
27.8%
Analyst Upside
+845.4%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ACHV
Achieve Life Sciences, Inc.
|
$7.24
|
$158.43M | - | 44 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$21.92
|
$154.27M | - | 68 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.94
|
$133.50M | - | 52 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$6.73
|
$114.01M | - | 44 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$24.80
|
$110.20M | - | 61 | Compare |
|
ALXO
ALX Oncology Holdings Inc. Common Stock
|
$1.22
|
$96.93M | - | 52 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$2.86
|
$84.52M | - | 59 | Compare |
|
PMVP
PMV Pharmaceuticals, Inc
|
$1.79
|
$72.07M | - | 45 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$9.68
|
$67.94M | - | 45 | Compare |
|
PASG
Passage Bio, Inc. Common Stock
|
$4.12
|
$25.84M | - | 34 | Compare |
More ALGS Analysis
Data updated: Oct 03, 2026 | Industry: Biotechnology (SIC 2836)
231 stocks in this industry